The shape and function of adherent cells cultured from rheumatoid synovial membranes are influenced by immune cells, and their products. The synovial cells produce collagenase and prostaglandin E2 (PGE2), the levels of which are increased when the cells are incubated with the monokine, mononuclear cell factor/interleukin 1. 
Introduction
The inflammatory synovial membrane of rheumatoid arthritis includes among other cells, T and B lymphocytes, monocyte/ macrophages, and fibroblastlike cells (1) . One of the earliest lesions described in rheumatoid arthritis is a proliferation of the synovial lining cells (2, 3) . Although there is marked variability in the distribution of cells even within a single synovial specimen from patients with active disease, a frequent finding is that of activated T lymphocytes clustered around monocytes which suggests a cell-mediated immune response to an antigen as yet unidentified (4, 5) . The association of the proliferating inflammatory synovium contiguous with bone erosions and disrupted capsules, ligaments, and tendons, which are the hallmark of the disease, suggests that proteolytic enzymes are involved in the extracellular degradation of the connective tissue matrix of the joint. We have previously shown that when cultures of the synovial lining membrane from patients with rheumatoid arthritis are established, the adherent cells produce latent collagenase among other proteases as well as prostaglandin E2 (PGE2)' (6) .
With age in culture and cell passage the spontaneous production of PGE2 and collagenase decreases, but can be augmented by the addition of a soluble factor from monocytes, which we have termed mononuclear cell factor. Mononuclear cell factor copurifies with interleukin 1 and has similar chemical properties (7) . In addition, partially purified conditioned medium from monocyte-enriched cells that contains mononuclear cell factor/interleukin 1 activity stimulates the synthesis of fibronectin as well as type I and III collagens by the synovial fibroblastlike cells (8) . T lymphocytes produce a soluble factor that stimulates the synthesis and release of mononuclear cell factor/interleukin 1 by monocytes, which in turn influences the function of the presumably nonimmune synovial cells (9-1 1). Fibroblasts in the area of a cell-mediated immune response could therefore be influenced by a variety of soluble signals elaborated by adjacent monocyte/macrophages and T lymphocytes.
The development of monoclonal antibodies to cell surface antigens has permitted a more precise evaluation of the cell types present in normal and abnormal tissues. By use of these antibodies, cells have been analyzed in blood, synovial fluid, and synovial tissue from patients with rheumatoid arthritis. Alterations in the ratio of T lymphocyte subsets, patterns of cell clustering in situ and expression of major histocompatibility complex class II (Ia-like) antigens have been observed (4, (12) (13) (14) (15) (16) (17) . The results of these studies have indicated several potential cellular interactions that might be involved in the synovial inflammation (18, 19), but have not defined functional relationships among the cells.
We undertook the present study by using our cell culture system to address the question of possible functional interrelationships, by attempting to define the phenotype of the cultured synovial cells and to evaluate the influence of immune cell products on the adherent synovial cells. Our results show that adherent synovial fibroblastlike cells continue to synthesize type I and III collagens while the expression of Ia antigens decreases in culture. Recombinant DNA-derived gamma interferon inhibits basal collagen synthesis as well as monocytestimulated collagen synthesis by these cells while at the same time inducing the de novo expression of class II (DR land DQ) antigens. Therefore, gamma interferon is not only a specific T lymphocyte factor for Ta expression by synovial fibroblasts but may also be responsible for lymphokine-mediated inhibition of collagen synthesis.
Methods
Cell culture. Adherent rheumatoid synovial cells were maintained in culture after enzymatic dispersion of the lining cells from synovial tissue obtained during joint surgery as previously described (6). Cells were grown in 100-mm diam tissue culture plates (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) in Dulbecco's modified Eagle's (DME) medium (Gibco Laboratories, Grand Island, NY), supplemented with 10% fetal calf serum (Bioproducts, Inc. Warrenton, OR), 100 U/ml penicillin, and 100 Ag/ml streptomycin (Gibco Laboratories) at 370C in a humidified atmosphere of 5% CO2 and 95% air.
Human foreskin fibroblasts (kindly provided by Dr. Richard Erbe, Genetics Unit, Massachusetts General Hospital) were cultured under similar conditions. Cells were passaged with trypsin (trypsin-EDTA, Gibco Laboratories).
Analysis of cell-associated antigens. A portion of rheumatoid synovial membrane was snap-frozen in liquid nitrogen and placed in OCT compound (Ames Co., Division of Miles Laboratories, Elkhart, IN) for tissue sections. Similar fragments of the synovial membrane were placed in formalin and processed for staining with hematoxylin and eosin. Dispersed cells were either cultured initially in four chamber tissue culture slides (Lab-Tek, Division of Miles Laboratories, Westmont, IL) or transferred to these chambers after trypsinization from 100-mm diam dishes. Cultures were allowed to recover from trypsinization for at least 24 h before analysis. The adherent synovial cells were analyzed using the following monoclonal antibodies: OKT3, OKT8, OKM1, OKIa (Ortho Pharmaceutical, Raritan, NJ) (20) , anti-Leu-l, anti-Leu-4, anti-HLA-DR (21), anti-Leu-M3 (22), anti-Leu-10 (DC/DS, now designated DQ [23] ) (24) (Becton-Dickinson Monoclonal Center, Mountain View, CA), anti-T4, anti-B1, anti-B2 (25) (Coulter clone, Coulter Diagnostics, Inc., Hialeah, FL), antivimentin (Labsystems, Inc., Chicago, IL) and anti-HLA (Bethesda Research Laboratories, Inc., Gaithersburg, MD) (26) . In addition, the presence of collagen was assessed using a monoclonal antibody to human type III collagen. The antibody (IgG2b) recognizes a helical, conformation-independent domain within the carboxyl-cyanogen bromide peptide al(III)CB5 or al(III)CB9 of human type III collagen. It does not cross-react with human types I, IV, and V collagens or bovine type II collagen (Moorhouse, C. M.,
Sear, and K. G. McCullagh, manuscript submitted for publication). Monoclonal antibody binding was assessed by avidin-biotin immunoperoxidase staining and quantitated using 'I-labeled second antibody. Immunoperoxidase staining was performed by use of the avidin-biotin complex method as previously described on air-dried and acetonefixed cells (27, 28) . Acetone-fixed frozen tissue sections or cells on tissue culture slides were incubated with normal horse serum for 10 min, followed by optimal dilutions of the monoclonal antibodies. After 30 min of incubation and washes, biotinylated horse anti-mouse IgG (Vector Laboratories, Burlingame, CA) diluted at 1:100 (previously absorbed with 10 mg each of human liver and kidney powders) was added and incubation continued for an additional 3 min followed by further washes. Endogenous peroxidase activity was (29) with and without reduction with 0.5% fl-mercaptoethanol. '4C-labeled rat tail tendon collagen (30) was used for molecular weight markers. The labeled collagen in the cell culture medium was further characterized after pepsinization at 4°C, and the collagens were analyzed by SDS-PAGE with delayed reduction to distinguish al(I) from al(III) chains (31) . Fluorograms of the gels were prepared as described (32 The cell-free conditioned medium was dialyzed against H20 (Spectropor membrane tubing, nominal molecular weight cutoff -3,500; Spectrum Medical Industries, Inc., Los Angeles, CA) and lyophilized. This crude conditioned medium from monocyte-enriched cells was used as the source of the collageninducing factor for fibroblasts in these experiments. Previous studies have shown that fibroblast collagen-inducing activity is present in AcA54 column fractions which also contain mononuclear cell factor/ interleukin I activity (8) .
Mononuclear cell factor assays. Mononuclear cell factor assays were performed as previously described (6) . After enzymatic dispersion of the synovial lining cells, the adherent cell population was prepared and maintained in culture as described above. Before bioassay adherent synovial cells were harvested with trypsin (trypsin-EDTA, Gibco Laboratories) and placed in 24-well trays at 5 X I04 cells per well. Samples to be tested were then diluted in DME medium (Gibco Laboratories) which contained 10% fetal calf serum and penicillin/streptomycin and incubated with the adherent synovial cells for 3 d. PGE2 production by the synovial cells was determined by radioimmunoassay (33) that used an antibody provided by Dr. L. Levine, Brandeis University, Waltham, MA.
Results
Analysis of synovial cells. The histologic appearance of the nine synovial samples used in these studies was consistent with the clinical diagnosis of rheumatoid arthritis with a prominent mononuclear cell infiltrate and synovial lining cell hyperplasia. Analysis with a panel of monoclonal antibodies and a twostep avidin-biotin immunoperoxidase stain confirmed previous reports describing clusters of T lymphocyte and monocytes (4, 14) . The adherent synovial cells cultured from these specimens and used in the mononuclear cell factor assay were then analyzed from the time of their initial culture through serial passages. Fig. 1 To investigate the possibility that only a subgroup of cells were responsive to gamma interferon, similar preparations of adherent synovial cells were maintained in culture for periods up to 4 mo and passaged six times before repeating the study. Incubation with gamma interferon again induced DR and DQ antigen expression on all cells. Similar results were obtained using normal skin fibroblasts (Fig. 4, C and D) . In addition, although the induction of DQ antigen (Leu-10) was detected in early-and late-passage adherent synovial cells and dermal fibroblasts, the staining intensity was less than for the DR antigen. The induction of Ia antigen expression by gamma interferon could be quantitated using an '2I-labeled second antibody. The effect of gamma interferon on DR expression was dose-dependent and was readily discernible at concentrations as low as 0.1 U/ml when assayed after 48 h of incubation (Table I) . DR expression was detected after 16 h of incubation, but was not evident at 8 h. The induction of DR antigens by gamma interferon was blocked by cycloheximide suggesting that new protein synthesis was necessary for this event as has been previously reported with other cell types (39 (Fig. 6 A-D) .
Effects of gamma interferon on collagen synthesis. To examine this effect in greater detail, skin fibroblasts were incubated with [3H]proline for the last 24 h of a 72-h culture and the medium was analyzed by SDS-PAGE and fluorography. As shown in Fig. 7 , preparations of monocyte-conditioned medium that contained mononuclear cell factor activity in- creased amino acid incorporation into proteins found in bands corresponding to fibronectin as well as partially processed and unprocessed procollagens as previously described (8), whereas gamma interferon inhibited basal as well as monokine-induced collagen and fibronectin synthesis. Further analysis of the collagens produced was performed by pepsin digestion of the [3H]proline-labeled conditioned medium followed by SDS-PAGE and delayed reduction which permitted separation of a1(I) from a1(III) chains (31) . As shown in Fig. 8 , gamma interferon inhibited basal as well as monokine-induced synthesis of a I(I), a2(I), and a1(III) chains. The effect of gamma interferon on the inhibition of collagen synthesis by adherent synovial fibroblastlike cells was dose-dependent as demonstrated in Fig. 9 . Because gamma interferon had profound but opposite effects on the synthesis of Ia antigens and collagens, we also evaluated the effect of this lymphokine on PGE2 production by the adherent synovial cells. Gamma interferon neither stimulated production of PGE2 by adherent synovial cells nor influenced mononuclear cell/interleukin 1-stimulated production (Table III) .
Discussion
The adherent synovial cells derived from the rheumatoid synovial membrane that persist in culture are fibroblastlike but are under the influence of multiple factors released by cells of the immune system. In the course of studies designed to characterize these adherent synovial cells, we have identified at least two discrete influences of the lymphokine gamma interferon on synovial fibroblasts, i.e., the induction of major histocompatibility complex class II antigens and the inhibition of collagen synthesis. The ability of gamma interferon to induce Ia antigens by skin fibroblasts has recently been described (37) . Our observations that synovial fibroblastlike cells upon initial isolation exhibited Ia antigens, the expression of which decreased with cell passage coincident with the loss of monocytes and lymphocytes, suggested an in situ immune-related event. The incubation of DR-negative cells with gamma interferon induced all of the adherent synovial cells to become HLA-DR-positive. These results suggest that the initial expression of Ia antigen by recently isolated adherent synovial cells is not an artifact of cell dispersion or culture in vitro.
The previous demonstration of Ia antigens on all synovial lining cells of the tissue of patients with rheumatoid arthritis is consistent with our findings (15) (16) (17) (45) .
It is becoming evident that specific immune signals can influence specific functions of the nonimmune synovial fibroblastlike cells. The monokine, mononuclear cell factor/interleukin 1, augments collagenase and PGE2 production by adherent synovial cells (7, 9, 46 (1 1, 47) . The factor present in monocyteconditioned medium which contains mononuclear cell factor/ interleukin 1 activity also stimulates the synthesis of types I and III collagens and fibronectin (8) but does not induce Ia expression. The T lymphocyte product, gamma interferon, activates tumoricidal capacity (macrophage-activating factor activity) (48, 49) and in addition increases Fc and fibronectin receptors and increases phagocytic capacity of monocyte/ macrophages (50) (51) (52) . Gamma interferon does not have mononuclear cell factor activity, however, nor does it alter mononuclear cell factor-stimulated PGE2 production by the synovial cells. Yet, gamma interferon, which stimulates cells to inhibit viral replication, has other diverse affects on the adherent fibroblastlike synovial cells. These studies clearly show that gamma interferon is a regulatory lymphokine that induces the de novo synthesis of Ia antigens in the same cells in which it inhibits the synthesis of collagen. In their characterization of dispersed cells from rheumatoid synovial membranes, Burmester et al. (53) identified three major cell populations by using several monoclonal antibodies: (a) monocyte antigen-, Fc receptor-, and Ia-positive, (b) monocyte antigen-and Fc receptor-negative, but Ia-positive and (c) monocyte antigen-and Ia-negative. On the basis of our observations, we suggest that some of the synovial fibroblastlike cells are included among the Ia positive-, Fc receptor-, and monocyte antigen-negative cells. These cells can assume diverse morphologic appearances varying from those of typical fibroblasts to those with a branched stellate character (34) If increased expression of Ia antigens on cells in the inflammatory synovium is due to the local production of gamma interferon, then we must also account for observations of others of decreased production of gamma interferon by peripheral blood T lymphocytes from patients with rheumatoid arthritis (63) . Cells in peripheral blood cells may not, however, be representative of the population in the synovial lesion as shown, for example, by the analysis of distribution of surface antigens on T lymphocytes (64) . In addition, cells from peripheral blood may function normally after growth in vitro as has been reported for the mRL-lpr/lpr mouse (65) . Indeed, when T lymphocytes from patients with rheumatoid arthritis are stimulated with allogeneic rather than autologous cells gamma interferon production is normal (63) . Thus these studies suggest that other factors in vivo may alter the apparent function of circulating cells.
The degree of Ia expression by cells, especially the DQ antigen, has been associated with the ability of cells to present antigen (66 
